SIM1 is a trivalent VHL-based BET PROTAC built from BET bromodomain inhibitor motifs connected through branched linkers to a von Hippel-Lindau ligand. Public sources describe it as capable of degrading BET family proteins with preference for BRD2, illustrating how multivalent architecture can alter potency, paralog preference, and degradation kinetics relative to classical bivalent degraders. The BET-recognition components engage bromodomain acetyl-lysine reader sites, while the VHL ligand recruits the VHL-associated ubiquitin-ligase complex. Mechanistically, SIM1 promotes formation of degradation-competent BET–PROTAC–VHL assemblies, resulting in ubiquitination and proteasomal removal of BET proteins. It is useful for studying trivalent PROTAC design, avidity effects, BET paralog selectivity, sustained transcriptional suppression, comparison of branched versus linear linkers, and the broader question of how molecular valency influences target engagement and degradation efficiency.
Structure of 2719051-84-8
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Target: SIM1 targets BET family proteins BRD2, BRD3, and BRD4, preferentially degrading BRD2.
Binding site: Its BET ligands bind acetyl-lysine recognition pockets within BET bromodomains.
Mechanism of action: SIM1 is a trivalent VHL-recruiting BET PROTAC constructed from BET bromodomain inhibitors connected to a von Hippel-Lindau ligand through branched linkers. This multivalent architecture enhances target engagement and promotes productive ternary-complex formation between BET proteins and VHL-containing ubiquitin ligase machinery. The resulting proximity enables ubiquitination and proteasome-dependent depletion of BRD2, BRD3, and BRD4, with preferential and rapid BRD2 degradation reported. SIM1 is useful for studying BET paralog dependency, multivalent degrader design, chromatin-reader turnover, and degradation-driven transcriptional suppression.
Applications• PROTAC-Mediated SIM1 Degradation: This application focuses on the use of SIM1-targeting PROTACs to facilitate the selective degradation of SIM1 protein. By recruiting E3 ligases, these PROTACs enable researchers to study the functional consequences of SIM1 depletion in cellular models, advancing understanding of its role in gene regulation and neuronal differentiation.
• Targeted Degradation in Neurobiology: Utilizing SIM1-specific PROTACs allows for precise protein degradation within neurobiological research. This approach aids in dissecting SIM1's involvement in neural development and function, providing valuable insights into its contribution to neurodevelopmental disorders and potential therapeutic strategies.
• Mechanistic Studies of SIM1 Pathways: PROTAC technology targeting SIM1 enables detailed investigation of its signaling pathways. By degrading SIM1, researchers can elucidate its interactions and downstream effects, facilitating the exploration of novel regulatory mechanisms and potential intervention points in cellular signaling networks.
• Functional Genomics via PROTACs: Employing SIM1-targeted PROTACs in functional genomic studies allows for the dynamic modulation of protein levels. This application supports the identification of SIM1's genetic interactions and regulatory networks, enhancing the understanding of its biological significance and potential as a therapeutic target.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.